← All stocks

Eloxx Pharmaceuticals, Inc.

ELOX Net buying
CIK 0001035354 #4592 in the set updated 22 Sep 2026
Bought (120 mo)
$47.30M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$47.30M
+$47.30M against sales at will

By person

23 insiders · 69 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kariv Tomer
Director
$13.31M (17)
+$13.31M
4,900,249
$3.53M
Nussbaum Ran
Director
$13.31M (17)
+$13.31M
4,900,249
$3.53M
Pontifax Management 4 G.P. (2015) Ltd. entity
10% owner
$13.31M (17)
+$13.31M
616,592
15.28%
$443.95K
PAREKH RAJESH B
Director
$3.33M (2)
+$3.33M
4,827,129
$3.48M
Kleijwegt Martijn
Director
$2.93M (1)
+$2.93M
2,953,673
73.17%
$2.13M
+11.3%
Shabtai Gilad
10% owner
$853.18K (4)
+$853.18K
3,351,770
83.04%
$2.41M
+2.7%
Ward Robert
FORMER CHAIRMAN AND CEO
$161.60K (2)
+$161.60K
244,267
6.05%
$175.87K
WEAVER GREGORY L
FORMER CHIEF FINANCIAL OFFICER
$38.52K (1)
+$38.52K
10,431
0.2584%
$7.51K
Geffken Daniel E.
INTERIM CFO
$36.00K (1)
+$36.00K
50,000
1.24%
$36.00K
Avnur Zafrira
Director
$20.98K (2)
+$20.98K
2,263
0.0561%
$1.63K
Aggarwal Sumit
President and CEO
1,672,756
41.44%
$1.20M
OPKO HEALTH, INC. entity
10% owner
1,289,818
31.95%
$928.67K
Domicilium Real Estate Fund III LP entity
10% owner
361,578
8.96%
$260.34K
MODUR VIJAY
HEAD OF R&D
154,953
3.84%
$111.57K
Noiman Silvia
Director
141,389
3.50%
$101.80K
Huertas Pedro
Chief Medical Officer
137,725
3.41%
$99.16K
Williams Gregory C.
CHIEF EXECUTIVE OFFICER
44,629
1.11%
$32.13K
Belloff Neil S.
COO, GENERAL COUNSEL &CORP SEC
32,699
0.8101%
$23.54K
Androski Lindsay
Director
15,750
0.3902%
$11.34K
Walts Alan Edmund
Director
15,567
0.3857%
$11.21K
Rubin Steven D
Director
14,625
0.3623%
$10.53K
Snow David P.
FORMER CHIEF BUSINESS OFFICER
7,359
0.1823%
$5.30K
Coastlands Capital LP entity
10% owner
0
0.0000%
$0.00
−100.0%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 164
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 14,206,520
History held since 16 Feb 2017